Laurel Wealth Advisors Inc. Has $227,000 Position in Clorox Company (The) (NYSE:CLX)

Laurel Wealth Advisors Inc. cut its stake in Clorox Company (The) (NYSE:CLX) by 8.4% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 1,690 shares of the company’s stock after selling 155 shares during the period. Laurel Wealth Advisors Inc.’s holdings in Clorox Company (The) were worth $227,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of CLX. American Beacon Advisors Inc. purchased a new stake in shares of Clorox Company (The) during the first quarter valued at $104,000. Quadrant Capital Group LLC boosted its stake in shares of Clorox Company (The) by 23.0% in the first quarter. Quadrant Capital Group LLC now owns 846 shares of the company’s stock valued at $106,000 after buying an additional 158 shares during the last quarter. Valley National Advisers Inc. boosted its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. boosted its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock valued at $122,000 after buying an additional 6 shares during the last quarter. Finally, Zions Bancorporation boosted its stake in shares of Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock valued at $134,000 after buying an additional 53 shares during the last quarter. 69.83% of the stock is currently owned by institutional investors.

Shares of Clorox Company (NYSE CLX) traded up 0.41% on Friday, hitting $137.73. The stock had a trading volume of 734,445 shares. The company has a market cap of $17.78 billion, a P/E ratio of 25.82 and a beta of 0.40. Clorox Company has a 12 month low of $111.24 and a 12 month high of $141.76. The company’s 50 day moving average price is $133.55 and its 200-day moving average price is $134.12.

Clorox Company (The) (NYSE:CLX) last posted its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The business had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The company’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.30 EPS. On average, analysts expect that Clorox Company will post $5.67 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Laurel Wealth Advisors Inc. Has $227,000 Position in Clorox Company (The) (NYSE:CLX)” was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this report can be viewed at https://www.com-unik.info/2017/08/19/clorox-company-the-nyseclx-shares-sold-by-laurel-wealth-advisors-inc-updated-updated-updated.html.

Several equities research analysts recently weighed in on the company. UBS AG reaffirmed a “sell” rating and issued a $121.00 price target (up from $117.00) on shares of Clorox Company (The) in a research note on Friday, May 5th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Finally, BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

What are top analysts saying about Clorox Company (The)? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Clorox Company (The) and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit